Jonas Bergman - Profile and Investment Details

Investor Profile

Jonas Bergman is a Venture Capital, Private Equity Firm, Venture Debt, Investment Partner, Investor based in Sweden with a diverse investment portfolio that includes companies such as Nutrie AB, Equilly AB, Stayble Therapeutics, Lumeotech, Equilab, Oterlu AI AB, Evispot AB, ZeroPoint Technologies AB, Promimic, Eneryield, Mimbly, Dialogtrail, Alpha Therapy Solution, Compular AB, Heap Carsharing, Press Kogyo, Yolean, Micvac, DetechtBokio, EQU8 Anti-Cheat, Epishine, Gastrofy, SalesByte AB, Evispot, Elypta, RaceOne, Addtruly, Vitroprobe Analytics AB, Modvion, Wavi Analytics AB, Metry, Aquammodate AB, Brinja, ReVibe Energy, Rdot Display, Scaffcalc AB, Micvac AB, TeXtreme, TRINE, Parakey, Mevia, Eperoto AB, In Singulo Solutions, Sigmastocks, Guinea Pig Health AB, Solartes AB, Atium, Amferia, YouPic, Safer Society, Vividye AB, Minalyze, Nyctea Technologies, Metry AB, Tummy Lab, BasedOn AB, Elpoalma AB, OMEN Technologies AB, Lucero AB, Winningtemp, Swedish Algae Factory, Aqua Robur Technologies, Envue Technologies AB, In Singulo Solutions AB, Aluwave, EmbeDL, LumenRadio, Monivent, Irisity AB (publ), . Over time, Jonas Bergman has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jonas Bergman is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Creative Venture, DeepTech, Tech Field Support, Apps, Strategic Partnerships, Engineering, Portfolio Management, Nordic Countries-based Startups, Medical Technologies, Startups, Information Technology (IT), Venture Fundraising, Business Development, Mobile, Biotechnology, Clean Technology, Networking, Entrepreneurship, Innovation, FinTech, Research, Consulting, Hardware, Marketing, Technology Transfer, Social Impact, Renewable Energy, Medical, B2B, Real Estate, Health Tech, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Jonas Bergman, as their portfolio suggests a familiarity and interest in this area.

Understanding Jonas Bergman’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.